ST ANDREWS PHARMACEUTICAL TECHNOLOGY LTD

12551706
Active Reading

Other professional, scientific and technical activities n.e.c.

3 employees website.com
Other professional, scientific and technical activities n.e.c.
S

ST ANDREWS PHARMACEUTICAL TECHNOLOGY LTD

12551706

Other professional, scientific and technical activities n.e.c.

Founded 8 Apr 2020 Active Reading, England 3 employees website.com
Other professional, scientific and technical activities n.e.c.

Previous Company Names

ZENOTOP LIMITED 8 Apr 2020 — 29 Oct 2020
Accounts Submitted 3 Oct 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 20 Apr 2026 Next due 21 Apr 2027 9 months remaining
Net assets £-3M £311K 2024 year on year
Total assets £1M £973K 2024 year on year
Total Liabilities £5M £1M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

9 Troutbeck Close Twyford Reading RG10 9DA England

Full company profile for ST ANDREWS PHARMACEUTICAL TECHNOLOGY LTD (12551706), an active company based in Reading, England. Incorporated 8 Apr 2020. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£1.20M

Increased by £1.12M (+1462%)

Net Assets

-£3.17M

Decreased by £311.07k (-11%)

Total Liabilities

£4.51M

Increased by £1.28M (+40%)

Turnover

N/A

Employees

3

Decreased by 1 (-25%)

Debt Ratio

336%

Decreased by 543 (-62%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 1,087,916 Shares £2.63m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
3 Jul 202517,708$1.26m$71.15
12 Dec 202413,281$912k$68.655
12 Dec 20244,427$315k$71.15
25 Oct 202142,500£8k£0.186
2 Feb 202120,000£4k£0.186

Officers

Officers

3 active
Status
Edey, DavidDirectorBritishEngland644 May 2020Active
Henry, William John, DrDirectorBritishUnited Kingdom708 Apr 2020Active
Hutchinson, Hazel CatherineDirectorIrishEngland674 May 2020Active

Shareholders

Shareholders (12)

Chris Taylor
24.1%
260,000
William John Henry
23.6%
254,700

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Dr William John Henry

British

Active
Notified 8 Apr 2020
Residence United Kingdom
DOB October 1955
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Dr William John Henry

British

Active
Notified 8 Apr 2020
Residence United Kingdom
DOB October 1955
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Christopher Joseph Crabtree Taylor

Ceased 1 Oct 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Apr 2026Confirmation StatementConfirmation statement made on 7 Apr 2026 with updates
20 Apr 2026OfficersAppointment of Claes Glassell as director
17 Apr 2026OfficersAppointment of Mr Claes Glassell as director on 16 Apr 2026
15 Apr 2026OfficersTermination of Claes Glassell as director on 12 Apr 2026
26 Feb 2026AddressChange Registered Office Address Company With Date Old Address New Address
20 Apr 2026 Confirmation Statement

Confirmation statement made on 7 Apr 2026 with updates

20 Apr 2026 Officers

Appointment of Claes Glassell as director

17 Apr 2026 Officers

Appointment of Mr Claes Glassell as director on 16 Apr 2026

15 Apr 2026 Officers

Termination of Claes Glassell as director on 12 Apr 2026

26 Feb 2026 Address

Change Registered Office Address Company With Date Old Address New Address

Recent Activity

Latest Activity

Confirmation statement made on 7 Apr 2026 with updates

2 months ago on 20 Apr 2026

Appointment of Claes Glassell as director

2 months ago on 20 Apr 2026

Appointment of Mr Claes Glassell as director on 16 Apr 2026

2 months ago on 17 Apr 2026

Termination of Claes Glassell as director on 12 Apr 2026

2 months ago on 15 Apr 2026

Change Registered Office Address Company With Date Old Address New Address

4 months ago on 26 Feb 2026